vs
Apellis Pharmaceuticals, Inc.（APLS）与IDACORP INC（IDA）财务数据对比。点击上方公司名可切换其他公司
IDACORP INC的季度营收约是Apellis Pharmaceuticals, Inc.的1.8倍（$360.1M vs $199.9M），IDACORP INC净利率更高（12.1% vs -29.5%，领先41.6%），IDACORP INC同比增速更快（-4.2% vs -5.9%），Apellis Pharmaceuticals, Inc.自由现金流更多（$-14.3M vs $-216.2M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs -7.2%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
IDACORP Inc是注册于美国爱达荷州、总部设在博伊西的电力控股企业，成立于1998年10月1日，旗下拥有爱达荷电力公司、IDACORP金融公司及Ida-West能源公司，业务覆盖电力供应、能源服务及相关配套金融服务领域。
APLS vs IDA — 直观对比
营收规模更大
IDA
是对方的1.8倍
$199.9M
营收增速更快
IDA
高出1.7%
-5.9%
净利率更高
IDA
高出41.6%
-29.5%
自由现金流更多
APLS
多$201.9M
$-216.2M
两年增速更快
APLS
近两年复合增速
-7.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $360.1M |
| 净利润 | $-59.0M | $43.6M |
| 毛利率 | — | — |
| 营业利润率 | -25.6% | 14.9% |
| 净利率 | -29.5% | 12.1% |
| 营收同比 | -5.9% | -4.2% |
| 净利润同比 | -62.2% | 15.1% |
| 每股收益（稀释后） | $-0.40 | $0.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSIDA
| Q4 25 | $199.9M | $360.1M | ||
| Q3 25 | $458.6M | $526.4M | ||
| Q2 25 | $178.5M | $449.3M | ||
| Q1 25 | $166.8M | $411.1M | ||
| Q4 24 | $212.5M | $375.9M | ||
| Q3 24 | $196.8M | $532.5M | ||
| Q2 24 | $199.7M | $442.6M | ||
| Q1 24 | $172.3M | $417.9M |
净利润APLSIDA
| Q4 25 | $-59.0M | $43.6M | ||
| Q3 25 | $215.7M | $124.4M | ||
| Q2 25 | $-42.2M | $95.8M | ||
| Q1 25 | $-92.2M | $59.6M | ||
| Q4 24 | $-36.4M | $37.9M | ||
| Q3 24 | $-57.4M | $113.6M | ||
| Q2 24 | $-37.7M | $89.5M | ||
| Q1 24 | $-66.4M | $48.2M |
营业利润率APLSIDA
| Q4 25 | -25.6% | 14.9% | ||
| Q3 25 | 48.7% | 27.5% | ||
| Q2 25 | -18.6% | 22.4% | ||
| Q1 25 | -50.0% | 13.4% | ||
| Q4 24 | -12.3% | 11.0% | ||
| Q3 24 | -24.0% | 25.1% | ||
| Q2 24 | -14.7% | 23.3% | ||
| Q1 24 | -36.0% | 11.9% |
净利率APLSIDA
| Q4 25 | -29.5% | 12.1% | ||
| Q3 25 | 47.0% | 23.6% | ||
| Q2 25 | -23.6% | 21.3% | ||
| Q1 25 | -55.3% | 14.5% | ||
| Q4 24 | -17.1% | 10.1% | ||
| Q3 24 | -29.2% | 21.3% | ||
| Q2 24 | -18.9% | 20.2% | ||
| Q1 24 | -38.5% | 11.5% |
每股收益（稀释后）APLSIDA
| Q4 25 | $-0.40 | $0.78 | ||
| Q3 25 | $1.67 | $2.26 | ||
| Q2 25 | $-0.33 | $1.76 | ||
| Q1 25 | $-0.74 | $1.10 | ||
| Q4 24 | $-0.30 | $0.72 | ||
| Q3 24 | $-0.46 | $2.12 | ||
| Q2 24 | $-0.30 | $1.71 | ||
| Q1 24 | $-0.54 | $0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $215.7M |
| 总债务越低越好 | — | $3.3B |
| 股东权益账面价值 | $370.1M | $3.6B |
| 总资产 | $1.1B | $10.2B |
| 负债/权益比越低杠杆越低 | — | 0.93× |
8季度趋势，按日历期对齐
现金及短期投资APLSIDA
| Q4 25 | $466.2M | $215.7M | ||
| Q3 25 | $479.2M | $333.2M | ||
| Q2 25 | $370.0M | $474.5M | ||
| Q1 25 | $358.4M | $634.5M | ||
| Q4 24 | $411.3M | $368.9M | ||
| Q3 24 | $396.9M | $427.9M | ||
| Q2 24 | $360.1M | $169.6M | ||
| Q1 24 | $325.9M | $157.6M |
总债务APLSIDA
| Q4 25 | — | $3.3B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $3.1B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $93.1M | — |
股东权益APLSIDA
| Q4 25 | $370.1M | $3.6B | ||
| Q3 25 | $401.2M | $3.5B | ||
| Q2 25 | $156.3M | $3.4B | ||
| Q1 25 | $164.2M | $3.3B | ||
| Q4 24 | $228.5M | $3.3B | ||
| Q3 24 | $237.1M | $3.3B | ||
| Q2 24 | $264.3M | $3.2B | ||
| Q1 24 | $266.7M | $2.9B |
总资产APLSIDA
| Q4 25 | $1.1B | $10.2B | ||
| Q3 25 | $1.1B | $10.1B | ||
| Q2 25 | $821.4M | $9.9B | ||
| Q1 25 | $807.3M | $9.6B | ||
| Q4 24 | $885.1M | $9.2B | ||
| Q3 24 | $901.9M | $9.1B | ||
| Q2 24 | $904.5M | $8.7B | ||
| Q1 24 | $831.9M | $8.3B |
负债/权益比APLSIDA
| Q4 25 | — | 0.93× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.92× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $137.8M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $-216.2M |
| 自由现金流率自由现金流/营收 | -7.1% | -60.0% |
| 资本支出强度资本支出/营收 | 0.1% | 98.3% |
| 现金转化率经营现金流/净利润 | — | 3.16× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $-577.5M |
8季度趋势，按日历期对齐
经营现金流APLSIDA
| Q4 25 | $-14.2M | $137.8M | ||
| Q3 25 | $108.5M | $162.8M | ||
| Q2 25 | $4.4M | $176.9M | ||
| Q1 25 | $-53.4M | $124.3M | ||
| Q4 24 | $19.4M | $136.4M | ||
| Q3 24 | $34.1M | $201.9M | ||
| Q2 24 | $-8.3M | $146.4M | ||
| Q1 24 | $-133.0M | $109.7M |
自由现金流APLSIDA
| Q4 25 | $-14.3M | $-216.2M | ||
| Q3 25 | $108.3M | $-127.9M | ||
| Q2 25 | $4.4M | $-156.4M | ||
| Q1 25 | $-53.4M | $-77.0M | ||
| Q4 24 | $19.3M | $-48.9M | ||
| Q3 24 | — | $-16.1M | ||
| Q2 24 | $-8.4M | $-199.6M | ||
| Q1 24 | $-133.3M | $-150.3M |
自由现金流率APLSIDA
| Q4 25 | -7.1% | -60.0% | ||
| Q3 25 | 23.6% | -24.3% | ||
| Q2 25 | 2.5% | -34.8% | ||
| Q1 25 | -32.0% | -18.7% | ||
| Q4 24 | 9.1% | -13.0% | ||
| Q3 24 | — | -3.0% | ||
| Q2 24 | -4.2% | -45.1% | ||
| Q1 24 | -77.3% | -36.0% |
资本支出强度APLSIDA
| Q4 25 | 0.1% | 98.3% | ||
| Q3 25 | 0.0% | 55.2% | ||
| Q2 25 | 0.0% | 74.2% | ||
| Q1 25 | 0.0% | 49.0% | ||
| Q4 24 | 0.0% | 49.3% | ||
| Q3 24 | 0.0% | 41.0% | ||
| Q2 24 | 0.0% | 78.2% | ||
| Q1 24 | 0.2% | 62.2% |
现金转化率APLSIDA
| Q4 25 | — | 3.16× | ||
| Q3 25 | 0.50× | 1.31× | ||
| Q2 25 | — | 1.85× | ||
| Q1 25 | — | 2.08× | ||
| Q4 24 | — | 3.60× | ||
| Q3 24 | — | 1.78× | ||
| Q2 24 | — | 1.63× | ||
| Q1 24 | — | 2.28× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
IDA
| Retailrevenues | $323.0M | 90% |
| Transmissionserviceswheeling | $18.6M | 5% |
| Energyefficiencyprogramrevenues | $11.7M | 3% |
| Wholesaleenergysales | $10.5M | 3% |
| Otherrevenues | $9.5M | 3% |
